Woodline Partners’s ADC Therapeutics ADCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.26M | Buy |
842,900
+27,369
| +3% | +$73.3K | 0.01% | 706 |
|
|
2025
Q1 | $1.15M | Sell |
815,531
-1,118,220
| -58% | -$1.58M | 0.01% | 752 |
|
|
2024
Q4 | $3.85M | Buy |
+1,933,751
| New | +$3.85M | 0.03% | 537 |
|
|
2023
Q2 | – | Sell |
-143,403
| Closed | -$280K | – | 619 |
|
|
2023
Q1 | $280K | Buy |
+143,403
| New | +$280K | ﹤0.01% | 563 |
|
|
2022
Q4 | – | Sell |
-47,567
| Closed | -$229K | – | 746 |
|
|
2022
Q3 | $229K | Buy |
47,567
+13,726
| +41% | +$66.1K | ﹤0.01% | 640 |
|
|
2022
Q2 | $269K | Buy |
+33,841
| New | +$269K | ﹤0.01% | 598 |
|